$PLUS

ePlus (NASDAQ:PLUS) Issues Earnings Results

ePlus (NASDAQ:PLUS) reported quarterly EPS of $1.00, slightly above analysts’ $0.98 consensus, and revenue of $576.17 million versus $569.25 million expected, according to FiscalAI. The stock fell $0.54 to $88.65 on Thursday. Institutional investors hold 93.8%.

Original reporting
Published May 28, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ePlus (NASDAQ:PLUS) Issues Earnings Results — source image
Decision brief

The 30-second read

$PLUSNeutralMed
01

Why it matters

The article centers on a quarterly earnings beat (EPS and revenue) alongside a same-day stock decline and recent analyst downgrades to Hold, suggesting the market may be discounting quality of earnings or forward outlook.

02

Market read

Traders can reassess near-term expectations after the earnings print, but the intraday drop and lack of guidance detail keep the setup mixed.

03

What to watch

No guidance, backlog, or segment commentary is included; insider selling and analyst downgrades to Hold could weigh on sentiment despite the beat.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session positioning following the earnings release

Background

ePlus is an enterprise/public-sector IT solutions provider spanning security, cloud, data center modernization, and unified communications.

Company-level read

Ticker impact

$PLUSNeutralMedium confidence
Context

ePlus reported quarterly EPS of $1.00 and revenue of $576.17M, beating consensus and moving the stock lower on the day.

Expected impact

Choppy/mean-reverting near-term; follow-through depends on management commentary and guidance not provided in the article.

Evidence & confidence

The article provides the printed beat and the intraday drop, but lacks guidance, margins detail beyond net margin, or qualitative drivers that typically explain post-earnings direction.

Market effects

Read-through for IT services/software integrators: earnings beats can support the group’s near-term confidence, but mixed price reaction tempers momentum.

Primarily US small/mid-cap tech/IT services sentiment; limited direct regional spillover indicated.

Low global relevance; impact likely contained to US-listed peers with similar enterprise IT spending exposure.

Counterpoint

The earnings beat may be less informative if investors expected stronger forward guidance or margin expansion; the intraday drop hints at that risk.

Key entities

  • ePlus Inc

    Reported $1.00 EPS and $576.17M revenue for the quarter; stock traded down $0.54 to $88.65.

  • Darren S. Raiguel

    COO sold 1,000 shares at an average $89.95 (Form 4 disclosure referenced).

  • Wall Street Zen / Zacks / Weiss Ratings

    Recent rating actions lowered PLUS to Hold from higher ratings.

Related articles

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.

$PLUSMed

ePlus (NASDAQ:PLUS) Surprises With Q2 CY2026 Sales

ePlus (NASDAQ:PLUS) reported Q2 CY2026 revenue of $649.1 million, up 1.9% year on year, exceeding market expectations. Non-GAAP profit was $1.28 per share, 11.8% above analysts’ consensus. The company cited extended lead times and shipment delays tied to an ongoing memory chip shortage.

$PLUSMed

EPLUS INC (PLUS): Results of Operations and Financial Condition

EPLUS INC (PLUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 5 ef20079242_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 ePlus Reports First Quarter Fiscal Year 2027 Financial Results Managed Services Delivers Strong Performance and Increases Recurring Revenue ~ Reiterates Fiscal 2027 Guidance ~ First Quarter of Fiscal Year 2027 ● Net sales

$PLUSMed

ePlus Reports First Quarter Fiscal Year 2027 Financial Results

ePlus (NASDAQ: PLUS) reported Q1 FY2027 results for the three months ended June 30, 2026. Net sales rose 1.0% to $649.1 million and services revenue rose 2.6% to $119.4 million, while gross profit fell 1.5% to $151.3 million. Net earnings from continuing ops declined 5.4% to $30.3 million and adjusted EBITDA fell 9.2% to $47.8 million. The company reiterated FY2027 mid-single-digit growth guidance and declared a $0.27 quarterly dividend.

$PLUSMed

PageGroup & Oxford Nanopore: Markets live

PageGroup shares rose over 11% after it reported Q2 gross profit of £198m, down 0.2% year on year but ahead of analyst expectations, and said it sees signs of market normalisation. ME Group International gained about 11% after interim results showed flat £154m sales. Plus500 shares fell on weaker cash margin, and Oxford Nanopore dropped 12% after H1 sales missed expectations at £116.5m.